Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AVP Reinforces Its Leadership Team: Warda Shaheen Joins AVP as a General Partner for the AVP Late Stage Fund in Europe, while Pedro Barros Takes on the Role of Partner in Charge of Investor Relations
-
Keytom Partners With 10 Leading Global Banks to Boost Seamless Payments for Clients
-
Lightweight, High Speed: Fujifilm Introduces FUJIFILM GFX100S II Mirrorless Digital Camera
-
Super Telephoto Powerhouse: Fujifilm Introduces FUJINON GF500mmF5.6 R LM OIS WR Lens
-
Calling All Creatives: Fujifilm Announces FUJIFILM X-T50 Mirrorless Digital Camera and FUJINON XF16-50mmF2.8-4.8 R LM WR Lens
-
MT Højgaard Holding A/S: Continued profitable growth in a slowing market
-
RUBIS: Company communication
-
IDEX Biometrics interim report for the first quarter of 2024
-
SAF production in France: Haffner Energy announces new strategic project
-
Weak first quarter
-
PARROT: 2024 FIRST-QUARTER BUSINESS
-
Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT
-
LIfT BioSciences Awarded Innovate UK Grant to Accelerate Product Development of New IMAN Cell Therapy Variants
-
Appointment of Joint Corporate Broker and Financial Adviser
-
Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
-
-
Transaction in Own Shares
-
Dividend payment ex-date of JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’
-
Fosun attends "Choose France" Summit for a third time
-
Skanska divests the first building of the office project Studio in Warsaw, Poland, for EUR 86M, about SEK 1 billion
-
A new breakthrough in thermal monocular----Pixfra Mile2 Series
-
SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch
-
REAL SIMPLE Teams Up with Pinterest for First-Ever Shoppable "Best & Brightest" Issue
-
XRP Healthcare Sponsors The Ehlers-Danlos Society, with Vital Support via its Prescription Savings Card
-
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity
-
Multitude SE initiates a written procedure to request certain amendments to the terms of its subordinated capital notes
-
Multitude SE initiates a written procedure to request certain amendments to the terms of its senior bonds due 2025
-
Maisons du Monde: First quarter 2024 Sales
-
IDEX - Ex. Repair Issue Today
-
Multitude SE with continued strong growth at the start of 2024: EBIT increases by 31 percent to EUR 11.6 million
-
Multitude SE: The Board of Directors of Multitude SE has decided to start a share buyback programme
-
CGG Changes Name to Viridien
-
TCM Group A/S: Interim report Q1 2024
-
-
BGHL (EUR): NAV(s)
-
First quarter 2024 financial information
-
BGHL (GBP): NAV(s)
-
Transaction in Own Shares
-
Vallourec First Quarter 2024 Results
-
KPS CAPITAL PARTNERS TO ACQUIRE INNOMOTICS FROM SIEMENS AG
-
Consolidated interim report 1 January – 31 March 2024
-
BUREAU VERITAS - Bureau Veritas successfully completes an inaugural A3 rated (by Moody’s) bond issuance of EUR 500 million with a maturity in May 2036
-
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
-
Aegon appoints Duncan Russell to succeed Matt Rider as Chief Financial Officer
-
BW LPG Limited - Q1 2024 Financial Report Release and Earnings Presentation on 30 May 2024
-
Vastned Belgium: Application of article 7:97 BCAC by the Board of Directors of Vastned Belgium
-
Vastned Retail and Vastned Belgium announce intention to merge
-
Start of Day Message
-
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity
-
VEON 1Q24 Trading Update: Accelerating USD Growth, Strong Operational Execution


